October 10, 2019 – Kaplan Fox & Kilsheimer LLP (“Kaplan Fox”) (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of The Chemours Company (“Chemours” or the “Company”) (NYSE: CC). A complaint has been filed in the United States District Court for the District of Delaware against the Company and certain executives. Investors who purchased Chemours’ common stock may be affected and should contact Kaplan Fox immediately.
October 10, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of Forescout Technologies, Inc.. (“Forescout” or the “Company”) (NASDAQ: FSCT).
October 10, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of ADTRAN, Inc. (NASDAQ: ADTN).
October 10, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of Monolithic Power Systems, Inc. (“Monolithic” or the “Company”) (Nasdaq: MPWR).
October 9, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of James River Group Holdings, Ltd. (“James River” or the “Company”) (NASDAQ: JRVR).
October 9, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased American Depository Shares of Ruhnn Holding Limited (“Ruhnn” or the “Company”) (Nasdaq: RUHN).
October 8, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased American Depository Shares of Jumia Technologies AG (“Jumia” or the “Company”) (NYSE: JMIA), a pan-African e-commerce platform which connects sellers with consumers.
October 4, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of SmileDirectClub, Inc. (“SDC” or the “Company”) (Nasdaq: SDC), a Nashville, Tennessee-based direct-to-consumer provider of orthodontic aligners.
October 1, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders.
September 27, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of Waitr Holdings Inc. (“Waitr” or the “Company”) (Nasdaq: WTRH), a Lake Charles, Louisiana-based operator of an online food ordering and delivery platform.
September 10, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of Sonim Technologies, Inc. (“Sonim” or the “Company”) (Nasdaq: SONM), a San Mateo, California-based provider of ruggedized mobile phones and accessories.
August 20, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of Sundial Growers Inc. (“Sundial” or the “Company”) (Nasdaq: SNDL), a “craft pioneering cannabis” company.
August 16, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of Myriad Genetics, Inc. (“Myriad” or the “Company”) (NASDAQ: MYGN).
August 6, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Just Energy Group Inc. (“Just Energy or the “Company”) (NYSE: JE). A complaint has been filed against the Company and certain executives. Investors who purchased Just Energy securities between November 9, 2017 and July 23, 2019, inclusive (the “Class Period”), may be affected.
August 6, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of GTT Communications, Inc. (“GTT or the “Company”) (NYSE: GTT). A complaint has been filed against the Company and certain executives. Investors who purchased GTT common stock between February 26, 2018 and July 1, 2019, inclusive (the “Class Period”), may be affected.
August 6, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of International Flavors & Fragrances (“IFF” or the “Company”) (NYSE: IFF).
August 1, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of Pluralsight, Inc. (“Pluralsight” or the “Company”) (Nasdaq: PS).
July 31, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of 2U, Inc. (“2U” or the “Company”) (Nasdaq: TWOU).
July 29, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of Capital One Financial Corporation (“Capital One” or the “Company”) (NYSE: COF).
July 26, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Eagle Bancorp, Inc. (“Eagle Bancorp” or the “Company”) (NASDAQ: EGBN), a bank holding company for EagleBank, Inc. (“EagleBank”), which provides commercial and consumer banking services. A complaint has been filed against the Company and certain executives and/or directors. Investors that purchased Eagle Bancorp securities between March 2, 2015 and July 17, 2019, inclusive (the “Class Period”), may be affected.
July 24, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Casa Systems, Inc. (“Casa Systems” or the “Company”) (NASDAQ: CASA). A complaint has been filed against the Company, certain executives and/or directors, and the underwriters of the Company’s December 15, 2017 initial public offering (the “IPO”) for alleged securities law violations. Investors that purchased Casa Systems’ common stock in or traceable to the Company’s IPO may be affected.
July 1, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Reckitt Benckiser Group PLC (“Reckitt” or the “Company”) (OTC: RBGLY). A complaint has been filed against the Company and certain executives and/or directors. Investors that purchased Reckitt American Depositary Shares (“ADSs”) between July 28, 2014 and April 9, 2019, inclusive (the “Class Period”), may be affected.
July 11, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of Omnicell, Inc. (“Omnicell” or the “Company”) (Nasdaq: OMCL).
July 10, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Diebold Nixdorf, Incorporated (“Diebold” or the “Company”) (NYSE: DBD). A complaint has been filed against the Company and certain executives. Investors that purchased Diebold securities between May 4, 2017 and July 4, 2017, inclusive (the “Class Period”), may be affected.
July 10, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Eros International Plc (“Eros” or the “Company”) (NYSE: EROS), a company that distributes Indian language films. A complaint has been filed against the Company and certain executives. Investors that purchased Eros securities between July 28, 2017 and June 5, 2019, inclusive (the “Class Period”), may be affected.
June 5, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Community Health Systems, Inc. (“Community Health” or the “Company”) (NYSE: CYH). A complaint has been filed against the Company, its CEO and Chairman of the Board, as well as certain other executives. Investors that purchased Community Health securities between February 20, 2017 and February 27, 2018, inclusive (the “Class Period”), may be affected.
June 5, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of RCI Hospitality Holdings, Inc. (“RCI” or the “Company”) (NASDAQ: RICK). A complaint has been filed against the Company and certain executives. Investors that purchased RCI securities between August 10, 2017 and May 10, 2019, inclusive (the “Class Period”), may be affected.
May 29, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of First American Financial Corp. (“First American” or the “Company”) (NYSE: FAF).
April 24, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of Apyx Medical Corporation (“Apyx Medical” or the “Company”) (NASDAQ: APYX), a company developing J-Plasma technology, a plasma-based surgical product for cutting, coagulation and ablation of soft tissue. A complaint has been filed in the United States District Court for the Middle District of Florida against the Company and its Chief Executive Officer. Investors that acquired Apyx Medical securities between August 1, 2018 and April 1, 2019, inclusive (the “Class Period”), may be affected.
| Company | Ticker | Class Period | Deadline | Administrator | |
|---|---|---|---|---|---|
| Xencor, Inc. | XNCR | On behalf of all former holders of Xencor, Inc.'s (the "Company") Series A-E preferred stock whose shares were converted to A-1 stock in the Recapitalization. | 5/13/17 | Strategic Claims Services | |
| Molycorp, Inc. | MCP | 2/21/2012 - 10/15/2013 | 5/18/17 | Angeion Group | |
| Health Enhancement Products, Inc. (N/K/A Zivo Bioscience, Inc.) | HEPI | 10/31/2003 - 5/31/2004 | 5/18/17 | Rust Consulting, Inc. | |
| Barclays Bank PLC (Electronic Foreign Exchange Trading - BARX) | n/a | 6/1/2008 - 4/21/2016 | 5/19/17 | Garden City Group | |
| EZCORP, Inc. | EZPW | 4/19/2012 - 10/6/2014 | 5/19/17 | Garden City Group | |
| King Digital Entertainment plc | KING | 3/26/2014 - 9/22/2014 | 5/23/17 | Gilardi & Co. |
| Elan Corporation, plc | ELN | On behalf of all persons: (i) who sold Elan Corporation, plc American Depositary Receipts contemporaneously defendants' purchases of Elan ADRs during the period August 23, 2006 through and including June 17, 2008 at 2:00 am EDT; and/or (ii) who purchased Elan ADRs, purchased call options thereon, or sold put options thereon, contemporaneously with the defendants' sales of Elan ADRs, sale of call options thereon, or purchases of put options thereon, during the period July 21, 2008 through and including July 29, 2008 at 4:00 pm EDT | 5/29/17 | A.B. Data, Ltd. | |
| PTC Inc. | PTC | 11/24/2011 - 7/29/2015 | 5/30/17 | Strategic Claims Services | |
| Revance Therapeutics, Inc. | RVNC | 6/19/2014 - 5/1/2015 | 6/5/17 | Gilardi & Co. | |
| Molycorp, Inc. | MCP | 2/7/2011 - 11/10/2011 | 6/14/17 | Gilardi & Co. | |
| CBD Energy Limited (n/k/a BlueNRGY Group Limited) | CBDE; CBDF | 6/13/2014 - 10/24/2014 | 6/29/17 | Strategic Claims Services | |
| Allco Finance Group Limited (Australia) | AFG | 8/21/2007 - 2/27/2008 | 6/30/17 | Maurice Blackburn | |
| Ampio Pharmaceuticals, Inc. | AMPE | 1/13/2014 - 8/21/2014 | 7/5/17 | Garden City Group | |
| FireEye, Inc. | FEYE | On behalf of all those who purchased FireEye, Inc. common stock in its March 6th, 2014 Secondary Public Offering | 7/8/17 | Kurtzman Carson Consultants | |
| Federal Home Loan Mortgage Corporation (SEC) | FRE; FMCC | 4/18/2000 - 6/8/2003 | 7/10/17 | Gilardi & Co. | |
| Altisource Portfolio Solutions S.A. | ASPS | 4/25/2013 - 12/21/2014 | 7/11/17 | Garden City Group | |
| Geron Corporation | GERN | 12/13/2012 - 3/11/2014 | 7/11/17 | Epiq Systems, Inc. | |
| Ruby Tuesday, Inc. | RT | 4/10/2013 - 10/9/2013 | 7/17/17 | Gilardi & Co. | |
| Third Avenue Focused Credit Fund | TFCVX; TFCIX | 3/1/2013 - 12/10/2015 | 7/19/17 | Gilardi & Co. | |
| L-3 Communications Holdings, Inc. (N/K/A L3 Technologies, Inc.) | LLL | 1/30/2014 - 7/30/2014 | 7/29/17 | Garden City Group | |
| Energy Recovery, Inc. | ERII | 3/7/2013 - 3/5/2015 | 8/4/17 | Garden City Group | |
| Dole Food Company, Inc. | DOLE | On behalf of all persons or entities who sold Dole Food Company, Inc.'s ("Dole" or the "Company") common stock (i) during the period from January 2, 2013 through October 31, 2013, inclusive, or (ii) on November 1, 2013 where those shares were sold on the open market and were not held as of the closing of the Take-Private Transaction. | 8/9/17 | JNG Legal Administration | |
| Halliburton Company | HAL | 8/16/1999 - 12/7/2001 | 8/12/17 | JND Legal Administration | |
| KBR, Inc. | KBR | 9/11/2013 - 7/30/2014 | 8/19/17 | Epiq Systems, Inc. | |
| DFC Global Corp. | DLLR | 1/28/2011 - 2/3/2014 | 9/4/17 | A.B. Data, Ltd. | |
| Sauer-Danfoss Inc. | SHS | 3/15/2013 - 4/12/2013 | 9/14/17 | Analytics, Inc. | |
| Covenant Partners, L.P. (SEC Fair Fund) | n/a | 1/1/1999 - 12/31/2014 | TBD | Securities and Exchange Commission | |
| FX Instruments (Canada) (UBS/BNP/Bank of America) | n/a | 1/1/2003 - 12/31/2013 | TBD | TBD | |
| Computer Sciences Corporation (SEC Fair Fund) | CSC | 8/5/2008 - 12/27/2011 | TBD | Garden City Group |